Jab1 has negative effects on p53-mediated genotoxic stresses

  • Lee, Eun-Woo (Department of Biotechnology and Bioengineering, Sungkyunkwan University) ;
  • Lee, Sang-Sik (Biomechatronics Center, Sungkyunkwan University) ;
  • Song, Jae-Whan (Department of Biotechnology and Bioengineering, Sungkyunkwan University)
  • Published : 2009.05.31


In this study, we use promoter analysis to show that interaction between Jab1 and p53 induces suppression of p53 activation in U2OS and H1299 cells. Interaction between p53 and Jab1 was further confirmed by immunoprecipitation and immunofluorescent analyses. In particular, Jab1 was able to induce nuclear export of p53 as previously reported. When Jab1 was overexpressed in U2OS cells followed by etoposide or hydrogen peroxide ($H_2O_2$), cell death induced by such stresses was protected against. On the contrary, when the level of Jab1 was suppressed in U2OS cells, cytotoxicity imposed by etoposide and $H_2O_2$ was dramatically increased, suggesting a cell protective role for Jab1. These results indicate that Jab1 is a negative regulator of p53 and a plausible oncogene.




  1. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331
  2. Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R. and Gu, W. (2003) Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302, 1972-1975
  3. Doronkin, S., Djagaeva, I. and Beckendorf, S. K. (2003) The COP9 signalosome promotes degradation of Cyclin E during early Drosophila oogenesis. Dev. Cell 4, 699-710
  4. Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., Pollmann, C. and Dubiel, W. (2001) COP9 signalosomespecific phosphorylation targets p53 to degradation by the ubiquitin system. Embo J. 20, 1630-1639
  5. Oh, W., Lee, E. W., Sung, Y. H., Yang, M. R., Ghim, J., Lee, H. W. and Song, J. (2006) Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J. Biol. Chem. 281, 17457-17465
  6. Yang, Y., Li, C. C. and Weissman, A. M. (2004) Regulating the p53 system through ubiquitination. Oncogene 23, 2096- 2106
  7. Wan, M., Cao, X., Wu, Y., Bai, S., Wu, L., Shi, X., Wang, N. and Cao, X. (2002) Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO Rep. 3, 171-176
  8. Callige, M., Kieffer, I. and Richard-Foy, H. (2005) CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome. Mol. Cell Biol. 25, 4349-4358
  9. Shen, L., Tsuchida, R., Miyauchi, J., Saeki, M., Honna, T., Tsunematsu, Y., Kato, J. and Mizutani, S. (2000) Differentiation- associated expression and intracellular localization of cyclin-dependent kinase inhibitor p27KIP1 and c-Jun co-activator JAB1 in neuroblastoma. Int. J. Oncol. 17, 749-754
  10. Kim, B. C., Lee, H. J., Park, S. H., Lee, S. R., Karpova, T. S., McNally, J. G., Felici, A., Lee, D. K. and Kim, S. J. (2004) Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol. Cell Biol. 24, 2251-2262
  11. Kouvaraki, M. A., Rassidakis, G. Z., Tian, L., Kumar, R., Kittas, C. and Claret, F. X. (2003) Jun activation domainbinding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27 (Kip1). Cancer Res. 63, 2977-2981
  12. Vousden, K. H. and Lu, X. (2002) Live or let die: the cell's response to p53. Nat. Rev. Cancer 2, 594-604
  13. Tomoda, K., Yoneda-Kato, N., Fukumoto, A., Yamanaka, S. and Kato, J. Y. (2004) Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J. Biol. Chem. 279, 43013-43018
  14. Korbonits, M., Chahal, H. S., Kaltsas, G., Jordan, S., Urmanova, Y., Khalimova, Z., Harris, P. E., Farrell, W. E., Claret, F. X. and Grossman, A. B. (2002) Expression of phosphorylated p27 (Kip1) protein and Jun activation domain- binding protein 1 in human pituitary tumors. J. Clin. Endocrinol. Metab. 87, 2635-2643
  15. Fukumoto, A., Ikeda, N., Sho, M., Tomoda, K., Kanehiro, H., Hisanaga, M., Tsurui, Y., Tsutsumi, M., Kato, J. Y. and Nakajima, Y. (2004) Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Oncol. Rep. 11, 277-284
  16. Ito, Y., Yoshida, H., Matsuzuka, F., Matsuura, N., Nakamura, Y., Nakamine, H., Kakudo, K., Kuma, K. and Miyauchi, A. (2003) Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression. Anticancer Res. 23, 4121-4125
  17. Shintani, S., Li, C., Mihara, M., Hino, S., Nakashiro, K. and Hamakawa, H. (2003) Skp2 and Jab1 expression are associated with inverse expression of p27 (KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology 65, 355-362
  18. Lee, E. W., Oh, W. and Song, J. (2006) Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53. Mol. Cells 22, 133-140
  19. Claret, F. X., Hibi, M., Dhut, S., Toda, T. and Karin, M. (1996) A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383, 453-457
  20. Goto, A., Niki, T., Moriyama, S., Funata, N., Moriyama, H., Nishimura, Y., Tsuchida, R., Kato, J. Y. and Fukayama, M. (2004) Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma. Pathol. Int. 54, 675-681
  21. Montes de Oca Luna, R., Wagner, D. S. and Lozano, G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206
  22. O'Brate, A. and Giannakakou, P. (2003) The importance of p53 location: nuclear or cytoplasmic zip code? Drug Resist. Updat. 6, 313-322
  23. Sui, L., Dong, Y., Ohno, M., Watanabe, Y., Sugimoto, K., Tai, Y. and Tokuda, M. (2001) Jab1 expression is associated with inverse expression of p27 (kip1) and poor prognosis in epithelial ovarian tumors. Clin. Cancer Res. 7, 4130-4135
  24. Tomoda, K., Kubota, Y. and Kato, J. (1999) Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398, 160-165
  25. Lane, D. P. (1992) Cancer. p53, guardian of the genome. Nature 358, 15-16

Cited by

  1. Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer vol.15, pp.3, 2014,